CDLX · NASDAQ
Cardlytics (CDLX) Stock Price & Fundamentals
Cardlytics (CDLX) closed at $377.06 on Oct 9, 2026, down 1.37% from the previous close of $382.31.
Share price, past year
1Y +24.23%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $377.06 |
| Sep 30, 2026 | $372.50 |
| Aug 31, 2026 | $361.86 |
| Jul 31, 2026 | $379.87 |
| Jun 30, 2026 | $399.68 |
| May 29, 2026 | $408.36 |
| Apr 30, 2026 | $371.63 |
| Mar 31, 2026 | $348.31 |
| Feb 27, 2026 | $353.87 |
| Jan 30, 2026 | $356.26 |
| Dec 31, 2025 | $337.19 |
| Nov 28, 2025 | $319.38 |
| Oct 31, 2025 | $306.91 |
Key statistics
- Market cap
- $2.06B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $169.05M
- Net income (TTM)
- −$100.28M
- Shares outstanding
- 5.5M
- Dividend yield
- —
- 52-week range
- $301.06 – $426.12
Cardlytics's market cap is $2.06B, based on a share price of $377.06 and 5.5M shares outstanding as of Jun 30, 2026.
Financials
Cardlytics reported revenue of $212.33M for fiscal 2025, down 16.93% from fiscal 2024.
Cardlytics reported a net loss of $103.49M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $212.33M | −16.9% | −$103.49M | −48.7% | −$1.95 | $8.81M |
| FY2024ended Dec 31, 2024 | $255.61M | −10.4% | −$189.30M | −74.1% | −$3.91 | −$10.39M |
| FY2023ended Dec 31, 2023 | $285.43M | +3.0% | −$134.70M | −47.2% | −$3.69 | −$852.00K |
| FY2022ended Dec 31, 2022 | $277.19M | +7.1% | −$465.26M | −167.9% | −$13.92 | −$55.08M |
| FY2021ended Dec 31, 2021 | $258.75M | +38.5% | −$128.57M | −49.7% | — | −$41.63M |
| FY2020ended Dec 31, 2020 | $186.89M | −11.2% | −$55.42M | −29.7% | — | −$13.01M |
| FY2019ended Dec 31, 2019 | $210.43M | +39.7% | −$17.14M | −8.2% | — | $3.18M |
| FY2018ended Dec 31, 2018 | $150.68M | +15.6% | −$53.04M | −35.2% | — | −$24.92M |
| FY2017ended Dec 31, 2017 | $130.37M | +15.6% | −$19.64M | −15.1% | — | −$23.32M |
| FY2016ended Dec 31, 2016 | $112.82M | — | −$75.70M | −67.1% | — | −$34.33M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $36.88M | −$14.88M | — |
| Q1 FY2026ended Mar 31, 2026 | $34.32M | −$4.48M | — |
| Q4 FY2025ended Dec 31, 2025 | $50.89M | −$8.25M | — |
| Q3 FY2025ended Sep 30, 2025 | $46.96M | −$72.67M | −$1.36 |
| Q2 FY2025ended Jun 30, 2025 | $58.04M | −$9.28M | −$0.18 |
| Q1 FY2025ended Mar 31, 2025 | $56.44M | −$13.28M | −$0.26 |
| Q4 FY2024ended Dec 31, 2024 | $68.27M | −$15.59M | — |
| Q3 FY2024ended Sep 30, 2024 | $61.11M | −$145.18M | −$2.90 |
Company profile
- Name
- Cardlytics, Inc.
- Ticker
- CDLX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Computer Programming, Data Processing, Etc.
- Headquarters
- 675 Ponce De Leon Avenue, Ne, Suite 4100, Atlanta, GA 30308
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001666071
Recent SEC filings
- Sep 11, 2026
- Aug 5, 2026
- Aug 5, 2026
- Jun 3, 2026
- May 20, 2026
- May 12, 2026
- May 7, 2026
- May 7, 2026
Frequently asked questions
What is Cardlytics's stock price?
Cardlytics (CDLX) closed at $377.06 on Oct 9, 2026, down 1.37% from the previous close of $382.31.
What is Cardlytics's market cap?
Cardlytics's market cap is $2.06B, based on a share price of $377.06 and 5.5M shares outstanding as of Jun 30, 2026.
How much revenue does Cardlytics make?
Cardlytics reported revenue of $212.33M for fiscal 2025, down 16.93% from fiscal 2024.
Does Cardlytics pay a dividend?
Cardlytics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Cardlytics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures